CR10703A - SILICON DERIVATIVES FOR OBTAINING IMAGES BY POSITRON EMISSION TOMOGRAPHY (PET) - Google Patents

SILICON DERIVATIVES FOR OBTAINING IMAGES BY POSITRON EMISSION TOMOGRAPHY (PET)

Info

Publication number: CR10703A
Authority: CR; Costa Rica
Prior art keywords: pet; positron emission; emission tomography; obtaining images; silicon derivatives
Prior art date: 2006-10-02

Application number

CR10703A

Other languages

Spanish (es)

Inventor

Ananth Srinivasan

Lutz Lehmann

Ulrike Rohn

Timo Stellfeld

Simon Ametamey

Ulrich Klar

Aileen Hohne

Linjing Mu

Original Assignee

Bayer Schering Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-02

Filing date

2009-04-01

Publication date

2009-06-25

2006-10-02 Priority claimed from EP06076823A external-priority patent/EP1908472A1/en

2006-10-11 Priority claimed from EP06076869A external-priority patent/EP1911452A1/en

2007-03-12 Priority claimed from EP07090043A external-priority patent/EP1970064A1/en

2007-04-23 Priority claimed from EP07090079A external-priority patent/EP1985624A3/en

2009-04-01 Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag

2009-06-25 Publication of CR10703A publication Critical patent/CR10703A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/008—Peptides; Proteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0834—Compounds having one or more O-Si linkage
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0896—Compounds with a Si-H linkage
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/12—Organo silicon halides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/086—Bombesin; Related peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Radiology & Medical Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Analytical Chemistry (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Optics & Photonics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)
Nuclear Medicine (AREA)

CR10703A 2006-10-02 2009-04-01 SILICON DERIVATIVES FOR OBTAINING IMAGES BY POSITRON EMISSION TOMOGRAPHY (PET) CR10703A (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP06076823A EP1908472A1 (en)	2006-10-02	2006-10-02	Silicon derivatives for PET imaging
EP06076869A EP1911452A1 (en)	2006-10-11	2006-10-11	Silicon-derivates for PET-Imaging
EP07090043A EP1970064A1 (en)	2007-03-12	2007-03-12	Silicon-derivatives for pet-imaging
EP07090079A EP1985624A3 (en)	2007-04-23	2007-04-23	Single step method of radiofluorination of biologically active compounds or biomolecules

Publications (1)

Publication Number	Publication Date
CR10703A true CR10703A (en)	2009-06-25

Family

ID=39030886

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CR10703A CR10703A (en)	2006-10-02	2009-04-01	SILICON DERIVATIVES FOR OBTAINING IMAGES BY POSITRON EMISSION TOMOGRAPHY (PET)

Country Status (21)

Country	Link
US (1)	US20090035215A1 (en)
EP (1)	EP2074135A2 (en)
JP (1)	JP2010505776A (en)
KR (1)	KR20090085599A (en)
AR (1)	AR062795A1 (en)
AU (1)	AU2007304508A1 (en)
BR (1)	BRPI0719956A2 (en)
CA (1)	CA2664700A1 (en)
CO (1)	CO6180444A2 (en)
CR (1)	CR10703A (en)
IL (1)	IL197817A0 (en)
MA (1)	MA30824B1 (en)
MX (1)	MX2009003617A (en)
NO (1)	NO20091735L (en)
PA (1)	PA8747601A1 (en)
PE (1)	PE20081173A1 (en)
SV (1)	SV2009003205A (en)
TN (1)	TN2009000100A1 (en)
TW (1)	TW200820988A (en)
UY (1)	UY30596A1 (en)
WO (1)	WO2008040441A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2627486T3 (en)	2010-01-25	2017-07-28	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Silylated biomolecules
JP5717138B2 (en) *	2011-05-23	2015-05-13	独立行政法人産業技術総合研究所	Protein immobilization surface modification material
CN105452262A (en) *	2013-06-06	2016-03-30	日产化学工业株式会社	Alkoxysilane compound, liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element
CA2982269C (en) *	2015-05-26	2023-12-05	The Regents Of The University Of California	Heteroaromatic silicon-fluoride-acceptors useful for 18f labeling of molecules and biomolecules, and methods of preparing same
US11464784B2 (en)	2017-09-15	2022-10-11	The Regents Of The University Of California	Inhibition of aminocylase 3 (AA3) in the treatment of cancer
WO2021226076A1 (en) *	2020-05-04	2021-11-11	The Research Foundation For The State University Of New York	Positron imaging tomography imaging agent composition and method for detection of bacterial infection
WO2022064812A1 (en) *	2020-09-28	2022-03-31	国立研究開発法人量子科学技術研究開発機構	Method for producing radioactive labeled substance, device for producing radioactive labeled substance, and method for evaporating and concentrating radioactive metal nuclide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5084555A (en) *	1989-08-21	1992-01-28	The Administrators Of The Tulane Educational Fund	An octapeptide bombesin analog
US5732578A (en) *	1995-02-24	1998-03-31	Hyundai Metal Co., Ltd.	Device for maintaining the horizontality of a door lock lever
TW432073B (en) *	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
US6639076B1 (en) *	1998-08-18	2003-10-28	Eli Lilly And Company	Growth hormone secretagogues
DE60022508T2 (en) *	1999-06-14	2006-06-08	Eli Lilly And Co., Indianapolis	INHIBITORS OF SERIN PROTEASES
WO2002044144A2 (en) *	2000-11-30	2002-06-06	Advanced Research And Technology Institute, Inc.	Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
GB0206750D0 (en) *	2002-03-22	2002-05-01	Amersham Plc	Radiofluorination methods
US7342095B2 (en) *	2003-02-20	2008-03-11	University Of South Florida	Peptidomimetic inhibitors of STAT activity and uses thereof
GB0305704D0 (en) *	2003-03-13	2003-04-16	Amersham Plc	Radiofluorination methods
WO2005077967A1 (en) *	2004-02-13	2005-08-25	The University Of British Columbia	Radiolabeled compounds and compositions, their precursors and methods for their production
US20080029548A1 (en) *	2006-05-05	2008-02-07	Ann De Wree	Fabric treatment dispensing package

2007
- 2007-09-07 US US11/851,936 patent/US20090035215A1/en not_active Abandoned
- 2007-09-07 EP EP07818173A patent/EP2074135A2/en not_active Withdrawn
- 2007-09-07 MX MX2009003617A patent/MX2009003617A/en not_active Application Discontinuation
- 2007-09-07 WO PCT/EP2007/008044 patent/WO2008040441A2/en not_active Ceased
- 2007-09-07 CA CA002664700A patent/CA2664700A1/en not_active Abandoned
- 2007-09-07 AU AU2007304508A patent/AU2007304508A1/en not_active Abandoned
- 2007-09-07 KR KR1020097009044A patent/KR20090085599A/en not_active Withdrawn
- 2007-09-07 JP JP2009530773A patent/JP2010505776A/en active Pending
- 2007-09-07 BR BRPI0719956-2A2A patent/BRPI0719956A2/en not_active IP Right Cessation
- 2007-09-10 TW TW096133834A patent/TW200820988A/en unknown
- 2007-09-14 AR ARP070104086A patent/AR062795A1/en unknown
- 2007-09-14 PE PE2007001246A patent/PE20081173A1/en not_active Application Discontinuation
- 2007-09-14 UY UY30596A patent/UY30596A1/en not_active Application Discontinuation
- 2007-09-14 PA PA20078747601A patent/PA8747601A1/en unknown
2009
- 2009-03-25 TN TN2009000100A patent/TN2009000100A1/en unknown
- 2009-03-26 IL IL197817A patent/IL197817A0/en unknown
- 2009-04-01 CR CR10703A patent/CR10703A/en not_active Application Discontinuation
- 2009-04-02 CO CO09034043A patent/CO6180444A2/en not_active Application Discontinuation
- 2009-04-02 SV SV2009003205A patent/SV2009003205A/en not_active Application Discontinuation
- 2009-04-30 NO NO20091735A patent/NO20091735L/en not_active Application Discontinuation
- 2009-04-30 MA MA31834A patent/MA30824B1/en unknown

Also Published As

Publication number	Publication date
AU2007304508A8 (en)	2009-05-14
MX2009003617A (en)	2009-04-22
SV2009003205A (en)	2009-10-19
JP2010505776A (en)	2010-02-25
WO2008040441A3 (en)	2009-01-08
UY30596A1 (en)	2008-05-02
CO6180444A2 (en)	2010-07-19
PA8747601A1 (en)	2009-08-26
EP2074135A2 (en)	2009-07-01
US20090035215A1 (en)	2009-02-05
NO20091735L (en)	2009-06-30
TN2009000100A1 (en)	2010-08-19
WO2008040441A2 (en)	2008-04-10
PE20081173A1 (en)	2008-11-06
AU2007304508A1 (en)	2008-04-10
MA30824B1 (en)	2009-10-01
BRPI0719956A2 (en)	2014-04-29
TW200820988A (en)	2008-05-16
AR062795A1 (en)	2008-12-03
IL197817A0 (en)	2009-12-24
CA2664700A1 (en)	2008-04-10
KR20090085599A (en)	2009-08-07

Publication	Publication Date	Title
PT103200B (en)	2006-08-24	POSITRON EMISSION TOMOGRAPHY SYSTEM (PET)
BRPI0921908A2 (en)	2015-12-29	x-ray imaging machine
BRPI0811979A2 (en)	2014-10-21	FORMULATION FOR MENINGITIS VACCINES
BRPI0817503A2 (en)	2015-05-05	Pyrimidine-Substituted Purine Derivatives
BRPI0819620A2 (en)	2017-06-13	toner cartridges for an imaging device.
BRPI0922450A2 (en)	2015-12-15	disposable part imaging system.
FI20070221A0 (en)	2007-03-19	X-ray restriction during dental imaging
PL2501437T3 (en)	2016-10-31	Flash X-ray radiator
EP2040477A4 (en)	2015-11-04	IMAGING DEVICE
EP2141552A4 (en)	2011-10-05	IMAGING DEVICE
CR10703A (en)	2009-06-25	SILICON DERIVATIVES FOR OBTAINING IMAGES BY POSITRON EMISSION TOMOGRAPHY (PET)
SE0702453L (en)	2007-11-07	Imaging device for radiation therapy systems
EP1919515A4 (en)	2011-06-22	F-18 peptides for pre targeted positron emission tomography imaging
FI20065267L (en)	2006-11-17	Arrangement for dental imaging
IL207853A0 (en)	2010-12-30	Contrast agents for applications including perfusion imaging
BRPI0906491A2 (en)	2015-07-14	Method for image reconstruction.
DE602008002886D1 (en)	2010-11-18	Imaging device
DE602008003088D1 (en)	2010-12-02	Imaging device
ZA200903011B (en)	2010-07-28	Silicon derivatives for pet imaging
DK2126621T3 (en)	2013-07-22	IMAGING DEVICE
FR2918475B1 (en)	2012-06-08	RADIATION IMAGING SYSTEM
DE602008000361D1 (en)	2010-01-21	X-ray source
DE602008003161D1 (en)	2010-12-09	Imaging device
DE602007004169D1 (en)	2010-02-25	Electrophotographic imaging process
UY33152A (en)	2011-07-29	ADEQUATE FORMULATIONS FOR DIAGNOSIS FOR IMAGES WITH PET

Legal Events

Date	Code	Title	Description
2014-04-24	FA	Abandonment or withdrawal (granting procedure)